Condensed Consolidated Statements of Changes in Equity - USD ($)	Total	Series B Redeemable Convertible Preferred Stock	Series C Convertible Preferred Stock	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning Balance at Jun. 30, 2015		$ 26	$ 0	$ 1,099,608	$ 117,104,936	$ (102,674,049)	$ (1,589,486)	$ 1,734,194
Beginning Balance (Shares) at Jun. 30, 2015		2,575	0	39,129,334
Net loss						(17,876,058)		(386,436)
Net currency translation adjustment							3,903
Issuance of common and preferred stock, net of costs and underwriting fees			$ 280	$ 80,000	19,211,913
Issuance of common and preferred stock, net of costs and underwriting fees (Shares)			28,048	8,000,000
Stock-based compensation				$ 2,708	1,271,908
Stock-based compensation (Shares)				270,791
Contribution of capital from noncontrolling interest								53,614
Conversion of preferred stock		$ (3)		$ 3,527	(3,524)
Conversion of preferred stock (Shares)		(275)		352,696
Ending Balance at Jun. 30, 2016	$ 16,635,688	$ 23	$ 280	$ 1,185,843	137,585,233	(120,550,108)	(1,585,583)	1,401,372
Ending Balance (Shares) at Jun. 30, 2016		2,300	28,048	47,752,821
Net loss	(13,373,540)					(13,373,540)		(271,061)
Net currency translation adjustment							886
Stock-based compensation				$ 1,083	1,553,484
Stock-based compensation (Shares)				108,364
Contribution of capital from noncontrolling interest	$ 0
Exercise of stock options				$ 1,200	67,200
Exercise of stock options (Shares)	120,000			120,000
Exercise of warrants				$ 292	(292)
Exercise of warrants (Shares)				29,162
Ending Balance at Mar. 31, 2017	$ 4,886,001	$ 23	$ 280	$ 1,188,418	$ 139,205,625	$ (133,923,648)	$ (1,584,697)	$ 1,130,311
Ending Balance (Shares) at Mar. 31, 2017		2,300	28,048	48,010,347